Statistics for Corcept Therapeutics (id:5252 CORT)
Valuation metrics
Market cap
5.41B
Enterprise value
4.99B
Trailing P/E (ttm)
41.02
Forward P/E
29.53
PEG ratio
29.53
Price/Sales (ttm)
8.61
Price/Book (mrq)
8.47
Enterprise Value/Revenue
7.93
Enterprise Value/EBITDA
34.60
Overview
Shares outstanding
104.78M
Float
85.66M
Shares short
17.05M
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
849.55K
Average volume (90 days)
Price summary
52-Week low
20.84
52-Week high
61.66
52-Week change
36.93%
Beta
3.00
50-Day moving average
53.44
200-Day moving average
36.90
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
22.56%
Operating margin
25.53%
Operational effectiveness
Return on assets
13.00%
Return on equity
25.77%
Income statement
Revenue (ttm)
6.11
Revenue per share (ttm)
6.11
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
475.89M
EBITDA
144.86M
Net income to common (ttm)
140.49M
Diluted EPS (ttm)
1.26
Quarterly earnings growth (yoy)
50.50%
Balance sheet
Total cash (mrq)
380.34M
Total cash per share (mrq)
3.63
Total debt (mrq)
6.79M
Total Debt/Equity (mrq)
1.06
Current ratio (mrq)
370.00%
Book value per share (mrq)
6.10
Cash flow
Cash flow statement
144.65M
Levered free cash flow (LFCF)
140.11M